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Calendula officinalis L. has been largely known for its topical anti-inflammatory properties; however, there are no experimental
evidences about its antiphlogistic effect at the gastric level. To investigate whether marigold might exert an activity against gastric
inflammation, a CH
2
Cl
2
extract obtained from C. officinalis flowers was evaluated in vitro on the NF-𝜅B pathway. The lipophilic
extract demonstrated a significant inhibitory effect on the NF-𝜅B driven transcription.The identification of active compounds was
conducted by a bio-guided fractionation of the extract that afforded 16 fractions. Fraction J exhibited a concentration-dependent
inhibitory activity on the NF-𝜅B driven transcription and significantly contributed to the antiphlogistic effect showed by CH
2
Cl
2
extract. The main components of fraction J were loliolide and the fucoside acetates of 𝛽-eudesmol and viridiflorol. HPLC analysis
of fractions D and E led to the identification and isolation of triterpene esters that showed a concentration-dependent inhibition
of the NF-𝜅B driven transcription, with faradiol-3-myristate and the corresponding aglycone being the most active compounds.
The present study provides some experimental evidences that Calendula officinalis L. may exert an anti-inflammatory activity on
the gastric district by the inhibition of the NF-𝜅B system, identifying the compounds responsible, at least in part, for the observed
effect.
1. Introduction
Calendula officinalis L. (marigold, Asteraceae) is an annual
herb of Mediterranean origin, widely cultivated as an orna-
mental plant. Dried flowers’ heads are characterized by the
presence of steroids, terpenoids, free and esterified triter-
penic alcohols (faradiol, arnidiol, and calenduladiol, mainly
as myristate), phenolic acids, flavonoids (quercetin, rutin,
narcissin, isorhamnetin, kaempferol), carotenoids, and other
minor compounds [1]. Marigold apolar extracts have been
largely applied for external use in the treatment of skin ulcer-
ations, eczema, and conjunctivitis [2]. Several studies, both in
vitro and in vivo, demonstrated (1) the biological properties of
preparations frommarigold flowers as antioedematous agent
[3–5], (2) the activity in wound healing [6–8], and (3) their
antioxidant properties, at both topical [9–12] and systemic
level [13–15]. Among secondary metabolites, the flavonoids,
the carotenoids, and the triterpene fatty acid esters seem to
be the major responsible for the anti-inflammatory activity
of Calendula officinalis [3–5, 16, 17].
Gastritis is one of the most common inflammatory dis-
eases, affecting about 50% of the world’s population. Gastric
mucosa is continuously exposed to many noxious factors and
substances that can alter its integrity and lead to inflamma-
tion.Among those factors, the infection byHelicobacter pylori
(H. pylori) is the most relevant one. H. pylori is a Gram-
negative pathogen that colonizes the stomach of humans and
primates and is classified as a carcinogen type I. Usually
acquired during childhood, the infection can persist in the
gastric district causing chronic gastritis or evolving intomore
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severe diseases, such as atrophic gastritis, peptic ulcer, or
gastric adenocarcinoma [18]. As a consequence of untreated
infections, the gastric epithelial cells secrete many cytokines
and chemokines that are attracted to the mucosal layer
neutrophils, lymphocytes, and macrophages responsible for
the maintenance of the inflammatory status. Several studies
indicate that nuclear factor 𝜅B (NF-𝜅B) plays a crucial role at
the molecular level of this process [19–21].
Aqueous preparations from marigold flowers have been
traditionally used for the treatment of gastrointestinal dis-
eases, such as gastritis, ulcers, and colitis. Two studies demon-
strated the efficacy of herbal mixtures containing marigold
in the therapy of duodenal ulcers, gastroduodenitis, and
chronic hyposecretory gastritis [22, 23] and amore recent one
described the hypoglycemic and gastroprotective activities of
Calendula officinalis L. in vivo [24]. Moreover, another work
showed the effect of marigold preparations in ameliorating
inflammatory symptoms in an animal model of ulcerative
colitis [25]. So far, no one has established the clinical effective-
ness of Calendula officinalis L. extracts as anti-inflammatory
agent by internal use [26]. Thus, the aim of this work was
(i) to evaluate in vitro the anti-inflammatory activity of a
CH
2
Cl
2
extract from marigold flowers in a cellular model
of gastritis and (ii) to identify mixtures and compounds
responsible for this effect by a bio-guided fractionation of
the CH
2
Cl
2
extract, considering the NF-𝜅B system as the
molecular target.
2. Materials and Methods
2.1. Reagents. Dulbecco’s modified Eagle’s medium
(DMEM)/F12 (1 : 1), penicillin, streptomycin, L-glutamine,
and trypsin-EDTAwere fromGibco (Life Technologies Italia,
Monza, Italy). Foetal bovine serum (FBS) and disposable
material for cell culture were purchased by Euroclone
(Euroclone S.p.A., Pero, Milan, Italy). Parthenolide, dim-
ethyl sulfoxide (DMSO), and all solvents (from Sigma-
Aldrich, Milan, Italy) were of high-performance liq-
uid chromatography purity grade (>98%). Tumor necrosis
factor alpha (TNF-𝛼) was from ImmunoTools (Friesoythe,
Germany). Human adenocarcinoma cells (AGS) were
purchased from European Collection of Cell Culture (EACC,
UK, cat number 89090402). NF-𝜅B-luc plasmid was a
kind gift from Professor N. Marx (Department of Internal
Medicine II-Cardiology, Ulm, Germany). Britelite plus was
from PerkinElmer (Monza, Italy).
Flash chromatography (FC) was performed by Merck
Kieselgel 60 (70 230mesh), Merck RP 18 LiChroprep (40–
65 𝜇m); TLC by Merck Kieselgel 60 PF254; high pressure liq-
uid chromatography (HPLC) by Merck Hitachi L7100 pump,
L7400 UV detector, D7500 integrator Rheodyne injector;
HPLC column and method by Synergi Hydro column (150
× 10mm, 4 𝜇m particle size, 80 A˚ pore size; Phenomenex,
Torrance, CA, USA), 5.0mL/min, 𝜆 = 210 nm. The eluents
were acetonitrile (ACN) (A) and ACN/water 50 : 50 v/v (B);
in method 1 the gradient was changed linearly from 0% to
85% A in 45min; in method 2 the eluent A was applied
in the gradient of 0% at 𝑡 = 0, 37% at 𝑡 = 30, 85% at
𝑡 = 31, 85% at 𝑡 = 45, and 100% at 𝑡 = 46min. Optical
rotations were measured on a Bellingham + Stanley ADP 440
polarimeter. NMRwas performed by Bruker Avance 400 (1H
at 400MHz, 13C at 100MHz), 5mm BBI probe, 𝛿 in ppm
using residual solvent signals as internal reference (CDCl
3
= 77.0, CHCl
3
= 7.26 and CD
2
HOD = 3.31), 𝐽 values in Hz,
multiplicities, and peak assignments from 1H, 1HCOSY, 1𝐽CH
(HSQC), 𝑛𝐽CH (HMBC), and NOESY experiments. NOESY
data are reported as correlation map(s) between protons
1H ↔ 1H; HMBC data are reported as (13C) → correlated
to 1H.MS was performed by Bruker Esquire LCmultiple ion
trap. Electrospray ionization (ESI) was as follows: positive ion
mode, capillary voltage 4000V, nebulizing pressure 30.0 psi,
drying gas flow 7mL/min, and temperature 300∘C. Electron
impact mass spectra (EIMS, HREIMS) were recorded on a
Kratos MS80 spectrometer with home-built data system and
electron ionization at 70 eV,m/z (rel.%).
2.2. Plant Material. Dry flowers of Calendula officinalis
L. (variety Calypso Orange Florensis) were obtained and
extracted as previously described [27, 28]. A voucher spec-
imen (number 20040929) is deposited at the Laboratory of
Bioorganic Chemistry (Trento, Italy).
2.3. Cell Culture. AGS cells (EACC number 89090402) were
grown in DMEM/F-12 medium supplemented with 100 units
penicillin/mL, 100mg streptomycin/mL, 2mM L-glutamine,
and 10% heat-inactivated foetal bovine serum.The cells were
incubated at 37∘C in humidified atmosphere with 5% CO
2
until confluence. For the NF-𝜅B driven transcription assay,
AGS cells were plated at the concentration of 1.5 × 104
cells/mL in 24-well plates with complete medium to reach
about 80% of confluence. After 48 h, medium was replaced
with FBS-free medium and cells were exposed for 24 h to the
compounds or fractions under study in the presence of TNF-
𝛼 (10 ng/mL) as proinflammatory stimulus. To study the NF-
𝜅B nuclear translocation, cells were plated in 10mm dishes (3
× 106 cells/dish) with fresh complete medium for 48 h. Then,
medium was replaced with FBS-free medium containing
increasing concentrations of fractions in the presence of
TNF-𝛼 (10 ng/mL) for 1 h. We previously found that the
fractions H and I are highly cytotoxic to AGS cells [28], so
these fractions were excluded from the biological assays.
2.4. Transient Transfection and Luciferase Reporter Assay. To
assess the effect of different fractions and isolated compounds
on the NF-𝜅B driven transcription, AGS cells were tran-
siently transfected by the calcium-phosphate method with
a plasmid containing the luciferase reporter gene under the
control of the E-selectin promoter with three NF-𝜅B binding
sites. Sixteen hours after transfection, cells were stimulated
with TNF-𝛼 (10 ng/mL), in the presence of CH
2
Cl
2
extract
(1–20𝜇g/mL) or fractions A–P and subfractions (0.05–
20𝜇g/mL) or individual compounds (1–50𝜇M). After 24 h,
cells were harvested and luciferase activity was measured
using Britelite plus reagent on a luminometer. Parthenolide
(final concentration 10 𝜇M) is a natural inhibitor of the NF-
𝜅B driven transcription [29]; it was used as positive control
and showed around 50% inhibition in all the experiments
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reported in the present study.TheNF-𝜅Bdriven transcription
activation was expressed as a percentage relative to TNF-𝛼
treatment alone (100%).
2.5. NF-𝜅B Nuclear Translocation. To clarify the effect of
marigold fractions on the NF-𝜅B pathway, we focused on the
nuclear translocation as well; AGS cells were stimulated with
TNF-𝛼 (10 ng/mL) in the presence or in the absence of the
CH
2
Cl
2
extract (2.5–10 𝜇g/mL) or fraction J (2.5–7.5𝜇g/mL)
for 1 h. Nuclear and cytoplasmatic extracts were obtained
with Nuclear Extraction Kit (Cayman Chemical Company,
Ann Arbor, MI, USA) following manufacturer instructions.
Briefly, cells were first pelleted and resuspended in ice-
cold hypotonic buffer. Addition of detergent (NP-40 10%)
broke the cell membranes allowing access to the cytoplas-
matic fraction while maintaining the integrity of the nuclear
membrane. After separation of the cytoplasmatic fraction,
the pelleted nuclei were lysed in ice-cold extraction buffer,
obtaining the nuclear fraction. Total protein concentration of
the nuclear extracts was determined by the Bradford method
[30]. 10 𝜇g of total nuclear extracts for each sample was used
for the measurement of nuclear NF-𝜅B (p65 subunit) using
a commercial ELISA kit (Cayman Chemical Company, Ann
Arbor, MI, USA).The NF-𝜅B nuclear quantity was expressed
as a percentage relative to TNF-𝛼 treatment alone (100%).
2.6. Statistical Analysis. Results represented the mean ±
s.d. of at least three independent experiments replicated in
duplicates or triplicates. Statistical analysis was performed
with GraphPad Prism 6.0 software, using one-way ANOVA
analysis of variance followed by Bonferroni’s post-hoc test.
The significance was set at 𝑃 < 0.05.
3. Results and Discussion
3.1. Effect of Marigold CH
2
Cl
2
Extract on the NF-𝜅B Pathway.
Calendula officinalis L. is a botanical worldwide known for
its topical anti-inflammatory properties that are supported
by clinical studies. Oral use of marigold infusions for the
treatment of gastrointestinal diseases, such as gastritis, is only
acknowledged in traditional medicine and is not currently
supported by clinical trials [26]. Among the components
of marigold flowers, triterpene fatty acid esters, present in
lipophilic extracts, are the main responsible for the anti-
inflammatory effects [3, 4, 16, 17]. However, internal use
of lipophilic preparations from marigold flowers is not
recommended for their renowned toxicity. In fact, our group
has recently succeeded in identifying fractions and pure
compounds which occur in the lipophilic extract from
Calendula officinalis flowers and are toxic at the gastric level
[28]. In the sameworkwe demonstrated that the composition
of lipophilic extract was not altered by gastric digestion.
Accordingly, two studies were performed both in vivo [5] and
ex vivo [31] and revealed that marigold extracts could exert
the anti-inflammatory effect even after oral administration.
In fact, the consumption of extracts frommarigold flowers led
to a decrease in plasmatic proinflammatory cytokines (TNF-
𝛼 and IL-1𝛽), indicating a stability of the anti-inflammatory
components through stomach passage [5, 31].
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Figure 1: Effect of CH
2
Cl
2
extract on the NF-𝜅B driven tran-
scription. AGS cells were transiently transfected with NF-𝜅B-luc
plasmid and treatedwith TNF-𝛼 in the presence of dichloromethane
extract (1–20 𝜇g/mL) for 24 h. The NF-𝜅B driven transcription was
proportional to luciferase signal measured. ∗𝑃 < 0.05, ∗∗𝑃 < 0.01,
and ∗∗∗𝑃 < 0.001.
In order to investigate if apolar constituents of marigold
could exert anti-inflammatory effects at the gastric levels via
inhibition of the NF-𝜅B pathway, the CH
2
Cl
2
extract was
assayed in a widely used human gastric epithelial cell line.
AGS cells were transfectedwith a reporter plasmid containing
the luciferase gene under the control of three NF-𝜅B respon-
sive elements. Cells were then incubated with the extract in
the presence of TNF-𝛼 as proinflammatory stimulus for 24 h.
Luciferase activity was directly proportional to activation
of the NF-𝜅B driven transcription. TNF-𝛼 alone increased
luciferase activity by about fivefold when compared with
the control cells. Dichloromethane extract obtained from
Calendula officinalis L. flower heads inhibited the NF-𝜅B
driven transcription in a concentration-dependent manner
(IC
50
of 6.31±0.68 𝜇g/mL,mean± s.d.), exhibiting a complete
inhibition of TNF-𝛼-induced NF-𝜅B activation at 20𝜇g/mL
(Figure 1).
When NF-𝜅B is activated by proinflammatory stimuli,
it translocates into the nucleus, where it promotes the tran-
scription of responsive genes, encoding for many mediators
of the gastric phlogistic process. To clarify if CH
2
Cl
2
extract
could inhibit NF-𝜅B nuclear translocation as well, AGS cells
were treated with TNF-𝛼 (10 ng/mL) as proinflammatory
stimulus in the presence of the extract (5–10 𝜇g/mL) for 1 h.
Cells were then lysed and nuclear fraction was separated; the
nuclear NF-𝜅B was quantified through a commercial ELISA
kit. Surprisingly CH
2
Cl
2
extract did not exert a significant
inhibitory effect on the NF-𝜅B nuclear translocation, thus
suggesting that differentmechanisms of the NF-𝜅B activation
cascade might be involved.
3.2. Bio-Guided Fractionation of CH
2
Cl
2
Extract and Char-
acterization of the Fractions. The identification of biologi-
cally active compounds occurring in the lipophilic extract
was achieved through a bio-guided fractionation. Briefly, a
portion of the CH
2
Cl
2
extract was subjected to FC on silica,
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Table 1: Bio-guided fractionation of CH
2
Cl
2
extract and IC
50
of fractions on the NF-𝜅B driven transcription. AGS cells were
transiently transfected with NF-𝜅B-luc plasmid and treated with
TNF-𝛼 in the presence of fractions (2.5–20 𝜇g/mL) for 24 h. NF-𝜅B
driven transcription was proportional to luciferase signal measured.
The inhibitory activity of fractions was considered significant if
≤50 𝜇g/mL.
Fraction Hexane : AcOEt IC
50
(mean ± s.d.)
A 95 : 5 ≥50𝜇g/mL
B 90 : 10 ≥50𝜇g/mL
C 80 : 20 ≥50𝜇g/mL
D 70 : 30 23.01 ± 8.51 𝜇g/mL
E 60 : 40 ≥50𝜇g/mL
F 50 : 50 ≥50𝜇g/mL
G 40 : 60 ≥50𝜇g/mL
H 30 : 70 TOXIC
I 20 : 80 TOXIC
J 10 : 90 4.29 ± 0.97 𝜇g/mL
K AcOEt 19.59 ± 5.77 𝜇g/mL
L AcOEt 15.52 ± 5.21 𝜇g/mL
M Acetone 12.84 ± 4.43 𝜇g/mL
N Acetone 11.59 ± 3.26 𝜇g/mL
O Act\iPrOH 9 : 1 7.82 ± 2.13𝜇g/mL
P Act\iPrOH 9 : 1 ≥50𝜇g/mL
increasing gradually the eluent polarity from hexane/EtOAc
95 : 5 to absolute EtOAc, and then washed with acetone.
This procedure afforded 16 fractions (A–P); the triterpene
esters were contained in fractions D-E (Table 1). All the
fractions were assayed on AGS cells for their cytotoxicity, as
previously described [28]. Nontoxic fractions were tested for
their biological activity on the NF-𝜅B driven transcription in
AGS cells stimulated with TNF-𝛼 for 24 h.
As shown in Table 1, 14 fractions were assayed but only 7
inhibited the NF-𝜅B driven transcription in a concentration-
dependent manner. FractionD showed only amild biological
activity, while the most active fractions were J and O,
with an IC
50
of 4.29 ± 0.97 𝜇g/mL and 7.82 ± 2.13 𝜇g/mL,
respectively. Fraction J exhibited an inhibitory activity on the
NF-𝜅B driven transcription comparable to that showed by
the CH
2
Cl
2
extract. Consequently, it was also assayed on the
NF-𝜅Bnuclear translocation, using the samemodel described
above. Fraction J (2.5–7.5 𝜇g/mL) did not inhibit the NF-𝜅B
nuclear translocation, thus confirming that both the extract
and fraction J could directly prevent the activation of NF-𝜅B
driven transcription. Namely, natural products present in the
CH
2
Cl
2
extract and in fraction J could exert their inhibitory
effect on the binding of NF-𝜅B to DNA. This mechanism
of action has already been demonstrated for other natural
compounds, such as the sesquiterpene lactone parthenolide
[32] and artemisinin [33, 34].
3.2.1. Biological Activity of Triterpene Esters Present in Frac-
tions D-E. All the biologically active fractions were analysed
in RP-HPLC to identify the components responsible for
the inhibitory effect on the NF-𝜅B driven transcription.
The analysis was firstly devoted to the identification and
isolation of triterpene esters present in marigold flowers that
have been previously described for their anti-inflammatory
properties [3, 4, 16, 17]. Thus, myristic esters of faradiol,
arnidiol, and calenduladiol were identified and isolated in
fractions D and E by HPLC analysis, as previously described
[27], and then assayed for their biological activity.
For the first time our results demonstrated that all
triterpenoid esters exhibited a significant and concentration-
dependent inhibitory activity of the NF-𝜅B driven transcrip-
tion (Figure 2). Triterpene alcohols are not present in CH
2
Cl
2
extract; however they could be released after ingestion of
marigold preparations and are thought to have a greater bio-
logical activity; thus we synthesized [27] and assayed them.
As expected, triterpene alcohols demonstrated a stronger
inhibitory effect on the NF-𝜅B driven transcription than
the corresponding esters (Figure 2). Faradiol and faradiol-3-
myristate were themost potent compounds (IC
50
30±7.3 𝜇M
and 10±2.6 𝜇M, resp.).However the relative concentrations of
these compounds in the extract (Figure 2) revealed that other
components contributed to the antiphlogistic effect shown by
the extract.
3.2.2. Identification and Biological Activity of Compounds
Present in Fraction J. Fraction J showed the strongest
inhibition of the NF-𝜅B driven transcription (IC
50
4.29 ±
0.97 𝜇g/mL) and its action was comparable to that observed
for the lipophilic extract. Thus, J was separated by HPLC
on RP-18 column (method 1), into two subfractions: the first
contained mainly loliolide (25% w/w), the second (8% w/w)
consisted of a mixture of few compounds. Loliolide is a bitter
component previously described in Calendula officinalis L.
flowers [35] and in other plants, including Fumaria officinalis,
and in different marine algae [36]. It was considered a
phytotoxic compound and a biomarker of photooxidative
alterations [36]. Recently, it did not exhibit any antiphlogistic
effect in a macrophage cell line stimulated with LPS [37].
According to these findings, loliolide revealed no activity
on the NF-𝜅B cascade in our cellular model, exhibiting a
10% inhibition on the NF-𝜅B driven transcription at the
concentration of 5𝜇M (corresponding to the IC
50
of fraction
J). The second subfraction inhibited the NF-𝜅B driven tran-
scription in a concentration-dependent manner (IC
50
3.11 ±
2.30 𝜇g/mL), largely contributing to the effect demonstrated
by fraction J. Subsequently, an improved analytical method
(method 2) allowed the separation of fraction J into 10 HPLC
peaks which corresponded to pure compounds. Those of
interest contained the following compounds: 1 (peak 1, 𝑡
𝑅
=
2.1min, mg 8.9); 2 (peak 4, 𝑡
𝑅
= 17.2min, mg 3.4); 3
(peak 6, 𝑡
𝑅
= 19.6min, mg 2.7). The compounds 2 and 3
were peracetylated and the products were analyzed by EI-MS
without any preliminary purification [28]. The examination
of 1D- and 2D-NMR spectra as well as the MS data of
those compounds allowed their structural characterization:
loliolide 1, 𝛽-eudesmol 11-O-𝛽-D-(2󸀠-acetyl)-fucopyranoside
2, and viridiflorol 10-O-𝛽-D-(2󸀠-acetyl)-fucopyranoside 3
(Figure 3). The spectroscopic data of loliolide were identical
with those from the literature [38]. This is the first report on
the isolation and structural elucidation of the natural product
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Faradiol
Faradiol-3-myristate
Compound
Faradiol-3-myristate 16.9
Arnidiol-3-myristate 6.7
Calenduladiol-3-myristate 1.2
Faradiol
Arnidiol
Calenduladiol
CH2Cl2 extract
IC50 (mean ± s.d.) CH2Cl2 extract (%)
—
—
—
—
6.31 ± 0.68𝜇g/mL
30 ± 7.3 𝜇M
30 ± 4.6 𝜇M
35 ± 5.8 𝜇M
10 ± 2.6 𝜇M
21 ± 5.2 𝜇M
19 ± 3.8 𝜇M
(c)
Figure 2: Effect of triterpene esters and the corresponding alcohols ((a) arnidiol-3-myristate, arnidiol; (b) calenduladiol-3-myristate,
calenduladiol; (c) faradiol-3-myristate, faradiol) on the NF-𝜅B driven transcription. AGS cells were transiently transfected with NF-𝜅B-luc
plasmid and treated with TNF-𝛼 in the presence of triterpene esters or alcohols (1–50𝜇M) for 24 h. The table reports the IC
50
values and
relative percentages (w/w) of triterpene esters in lipophilic extract.
2; spectral data of compound 3 has been previously reported
[39] but the authors assigned the opposite configuration at
C-10.
Compound 2: C
23
H
38
O
6
, white, amorphous powder;
[𝛼]
25
D +10.0 (c 0.4, CHCl3); ESI-MS (positive mode): m/z
433 [M+Na]+; MS2 of [M+Na]+ m/z 229 [M+Na-C
15
H
24
]+,
MS3 of [M+Na]+ → [M+Na-C
15
H
24
]+ m/z 211 [M+Na-
C
15
H
24
-H
2
O]+; EIMS: m/z 273 [M-C
15
H
25
O]+ (28), 204
[M-C
12
H
18
O
8
]+∙ (20), 43 (100). HREIMS: m/z 273.0973
(calcd. for C
12
H
17
O
7
, 273.0974), 204.1878 (calcd. for C
15
H
24
,
204.1878). 1H NMR (CDCl
3
, 400MHz) 𝛿: ∼1.49 (1H, m, H-
1𝛽), 1.16 (1H, dd, H-1𝛼), ∼1.59 (2H, m, H-2), 2.29 (1H, br.d,
H-3𝛽), 1.98 (1H, br.q, H-3𝛼), 1.72 (1H, br.d, 𝐽 = 12.0Hz, H-5),
1.66 (1H, br.d, 𝐽 = 12.7Hz, H-6𝛼), 1.09 (1H, q, 𝐽 = 12.0Hz,
H-6𝛽), 1.44 (1H, tt, H-7), ∼1.57 (1H, m, H-8𝛼), ∼1.23 (1H, m,
H-8𝛽), 1.42 (1H, br.d, H-9𝛽), ∼1.25 (1H, m, H-9𝛼), 1.17 (3H,
s, H-12), 1.21 (3H, s, H-13), 0.68 (3H, s, H-14), 4.70 (1H, br.s,
H-15a), 4.42 (1H, br.s, H-15b), 4.54 (1H, d, 𝐽 = 7.9Hz, H-1󸀠),
4.82 (1H, dd, 𝐽 = 9.7, 7.9Hz, H-2󸀠), 3.62 (1H, br.d, H-3󸀠), 3.69
(1H, br.d, 𝐽 = 3.6Hz, H-4󸀠), 3.61 (1H, br.q, H-5󸀠), 1.32 (3H,
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Figure 3: Chemical structure of compounds identified in fraction J.
d, 𝐽 = 6.6Hz, H-6󸀠), 2.10 (3H, s, H-2󸀠󸀠); 13C NMR (CDCl
3
,
100MHz) 𝛿: 41.4 (t, C-1), 23.5 (t, C-2), 36.9 (t, C-3), 150.8 (s,
C-4), 49.8 (d, C-5), 24.6 (t, C-6), 48.4 (d, C-7), 22.2 (t, C-8),
41.9 (t, C-9), 36.0 (s, C-10), 80.1 (s, C-11), 22.8 (q, C-12), 25.0
(q, C-13), 16.4 (q, C-14), 105.3 (t, C-15), 95.0 (d, C-1󸀠), 73.5 (d,
C-2󸀠), 73.9 (d, C-3󸀠), 72.1 (d, C-4󸀠), 69.9 (d, C-5󸀠), 16.5 (q, C-
6󸀠), 171.2 (s, C-1󸀠󸀠), 21.0 (q, C-2󸀠󸀠); NOESY: 14 ↔ 2 and 6𝛽 and
8𝛽; 3𝛽 ↔ 15a; 15b ↔ 6𝛼 and 6𝛽; 1󸀠 ↔ 12 and 13. HMBC: (1)
→ 14; (10) → 14; (5) → 14; (7) → 12 and 13; (11) → 1󸀠 and
12 and 13; (1󸀠󸀠) → 2󸀠󸀠.
Compound 3: C
23
H
38
O
6
, white, amorphous powder;
[𝛼]
25
D –6.8 (c 0.15, CHCl3); ESI-MS (positive mode): m/z
433 [M+Na]+; MS2 of [M+Na]+: m/z 229 [M+Na-C
15
H
24
]+.
EIMS:m/z 494 [M]+∙ (0.3), 273 [M-C
15
H
25
O]+ (16), 204 [M-
C
12
H
18
O
8
]+∙ (71), 43 (100). HREIMS: m/z 494.2870 (calcd.
for C
27
H
42
O
8
, 494.2880), 273.0975 (calcd. for C
12
H
17
O
7
,
273.0974), 204.1871 (calcd. for C
15
H
24
, 204.1878). 1H NMR
(CDCl
3
, 400MHz) 𝛿: ∼1.88 (1H,m, H-1), ∼1.60 (2H,m, H-2),
∼1.81 (1H,m, H-3𝛽), ∼1.28 (1H,m, H-3b), ∼1.92 (1H,m, H-4),
1.70 (1H, m, H-5), 0.07 (1H, t, 𝐽 = 9.5Hz, H-6), 0.58 (1H, td,
𝐽 = 9.5, 9.5, 7.9Hz, H-7), ∼1.53 (2H, m, H-8), ∼1.76 (1H, m,
H-9𝛽), ∼1.57 (1H, m, H-9b), 0.95 (3H, s, H-12), 1.00 (3H, s,
H-13), 1.17 (3H, s, H-14), 0.92 (3H, d, 𝐽 = 6.7Hz, H-15), 4.58
(1H, d, 𝐽 = 7.9Hz, H-1󸀠), 4.85 (1H, dd, 𝐽 = 7.9, 9.5Hz, H-2󸀠),
3.59 (1H, m, H-3󸀠), 3.67 (1H, br.d, 𝐽 = 4Hz, H-4󸀠), 3.58 (1H,
qd, 𝐽 = 6.5, 1.0Hz, H-5󸀠), 1.30 (3H, d, 𝐽 = 6.5Hz, H-6󸀠), 2.09
(3H, s, H-2󸀠󸀠); 1HNMR (CD
3
OD, 400MHz) 𝛿: ∼1.94 (1H,m,
H-1), 1.71–1.55 (2H, m, H-2), ∼1.83 (1H, m, H-3a), ∼1.28 (1H,
m, H-3b), ∼1.96 (1H, m, H-4), ∼1.73 (1H, m, H-5), 1.23 (1H,
t, H-6), 0.60 (1H, ddd, H-7), 1.59 (H, m, H-8a), ∼1.47 (H, m,
H-8b), ∼1.74 (1H,m, H-9a), ∼1.62 (1H,m, H-9b), 0.97 (3H, s,
H-12), 1.01 (3H, s, H-13), 1.18 (3H, s, H-14), 0.94 (3H, d, H-15),
4.63 (1H, d, H-1󸀠), 4.96 (1H, dd, H-2󸀠), 3.64–3.60 (3H, m, H-
3󸀠 and H-4󸀠 and H-5󸀠), 1.23 (3H, d, H-6󸀠), 2.05 (1H,m, H-2󸀠󸀠);
13C NMR (CDCl
3
, 100MHz) 𝛿: 54.2 (d, C-1), 25.4 (t, C-2),
28.9 (t, C-3), 38.4 (d, C-4), 39.7 (d, C-5), 22.1 (d, C-6), 28.7 (d,
C-7), 18.2 (t, C-8), 37.9 (t, C-9), 82.0 (s, C-10), 18.7 (s, C-11),
16.1 (q, C-12), 28.6 (q, C-13), 26.6 (q, C-14), 16.2 (q, C-15), 94.5
(d, C-1󸀠), 73.7 (d, C-2󸀠), 73.9 (d, C-3󸀠), 72.2 (d, C-4󸀠), 69.8 (d,
C-5󸀠), 16.5 (q, C-6󸀠), 171.1 (s, C-1󸀠󸀠), 21.0 (q, C-2󸀠󸀠); NOESY: 6
↔ 3b and 7 and 13 and 15; 5 ↔ 12; 1󸀠 ↔ 1 and 14; 2󸀠󸀠↔ 12.
HMBC: (1) → 14; (9) → 14; (10) → 14 and 1󸀠; (6) → 12 and
13; (7) → 12 and 13; (11) → 12 and 13; (1󸀠󸀠) → 2󸀠 and 2󸀠󸀠.
We assayed the 10 peaks for their biological activity on
AGS cells. All compounds exhibited amild inhibitory activity
on the NF-𝜅B driven transcription (Figure 4), thus pointing
out that together they participate in the biological effect of
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Figure 4: Effect of fractions J.1–J.7 on the NF-𝜅B driven transcrip-
tion. AGS cells were transiently transfected with NF-𝜅B-luc plasmid
and treated with TNF-𝛼 in the presence of fractions (5𝜇g/mL) for
24 h.The NF-𝜅B driven transcription was proportional to luciferase
signal measured. ∗𝑃 < 0.05, ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001.
fraction J. We identified peak 1 as loliolide and peaks 4 and
6 as the fucoside acetates of 𝛽-eudesmol and viridiflorol,
respectively. Similar glycosides were previously described as
components of Calendula persica C. Mey [40] and many
additional analogues have been recently characterized in
Calendula officinalis L. flowers [28]. It has been shown that
𝛽-eudesmol exerts an anti-inflammatory activity in vitro [41,
42] through inhibition of the NF-𝜅B driven transcription
and activation at concentrations (𝜇molar order) similar to
that occurring in fraction J [42]. These evidences are in
agreement with our results obtained on fraction J and led to
the hypothesis that the presence of derivatives of 𝛽-eudesmol
might explain the inhibitory effect of fraction J on the NF-𝜅B
activation.
4. Conclusions
The present study provides some experimental evidence that
lipophilic preparations from Calendula officinalis L. may
exert an anti-inflammatory activity on the gastric district
through the inhibition of the NF-𝜅B system. Results obtained
through a bio-guided fractionation of a lipophilic extract
from marigold flowers show for the first time that the
inhibitory effect demonstrated by the extract on the NF-𝜅B
activation could be ascribed to the presence of a mixture
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of components (the so-called phytocomplex) among which
triterpene esters and derivatives of 𝛽-eudesmol play a pivotal
role.
The results described in this work could be of great
interest for the following reasons: (1) in the present study,
the anti-inflammatory activity of a lipophilic extract from
marigold flowers has been proven for internal use. Despite
the toxicity renowned for this type of extract, now, in the
literature, toxic events after oral administration of marigold
preparations are not reported; (2) even if other in vivo studies
are needed to confirm the antiphlogistic activity and the
safety of this type of extract, the identification of some
biologically active compounds could be the first step for
the formulation of preparations enriched with individual
components or extracts from marigold (as faradiol esters or
𝛽-eudesmol derivatives) useful in the treatment or prevention
of gastric inflammatory diseases.
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